Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 483 entries
View as:

Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice

Phase: N/A Priority: Normal
NCT ID: NCT04130750 Org: User:
Start: 12/31/19 End: 12/31/21 Due: 12/31/22

The Effect of Overtime Pancreaticoduodenectomy on the Short-term Prognosis of Patients(EOPSPP)

Phase: N/A Priority: Normal
NCT ID: NCT04881734 Org: User:
Start: 01/01/21 End: 04/29/21 Due: 04/29/22

Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT06075927 Org: User:
Start: 11/01/23 End: 10/30/25 Due: 10/30/26

Speech Perception Impairment Follow Complete Recovery of Sudden Sensorineural Hearing Loss

Phase: N/A Priority: Normal
NCT ID: NCT05608161 Org: User:
Start: 11/10/22 End: 05/31/23 Due: 05/31/24

Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT05932524 Org: User:
Start: 07/07/23 End: 06/30/25 Due: 06/30/26

Allo-HSCT as First-line Consolidation in High-risk PTCL

Phase: N/A Priority: Normal
NCT ID: NCT03672084 Org: User:
Start: 01/01/19 End: 12/31/23 Due: 12/31/24

Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing

Phase: N/A Priority: Normal
NCT ID: NCT03320044 Org: User:
Start: 10/18/17 End: 12/31/18 Due: 12/31/19

C-CAR011 Treatment in Subjects With ALL After HSCT

Phase: N/A Priority: Normal
NCT ID: NCT03327285 Org: User:
Start: 03/01/18 End: 04/30/21 Due: 04/30/22

Effects of OCTA-guided PDT in Acute CSC

Phase: N/A Priority: Normal
NCT ID: NCT03497000 Org: User:
Start: 09/01/17 End: 03/27/18 Due: 03/27/19

The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination

Phase: N/A Priority: Normal
NCT ID: NCT06751251 Org: User:
Start: 01/01/25 End: 10/01/26 Due: 10/01/27

NK Cell Infusion for Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04221971 Org: User:
Start: 10/31/20 End: 04/30/22 Due: 04/30/23

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06549855 Org: User:
Start: 10/31/24 End: 10/31/29 Due: 10/31/30

Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05087589 Org: User:
Start: 11/20/21 End: 10/01/23 Due: 10/01/24

The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA

Phase: N/A Priority: Normal
NCT ID: NCT06069180 Org: User:
Start: 11/15/23 End: 12/31/25 Due: 12/31/26

Morphological Analysis and Classification of Posterior Malleolar Fractures Based on CT Scans

Phase: N/A Priority: Normal
NCT ID: NCT05159258 Org: User:
Start: 01/01/13 End: 11/01/20 Due: 11/01/21

Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT01987791 Org: User:
Start: 01/31/05 End: - Due: -

Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells

Phase: N/A Priority: Normal
NCT ID: NCT06302465 Org: User:
Start: 05/01/24 End: 12/31/26 Due: 12/31/27

the Effect of a New Type of Pelvic Floor Rehabilitation Device PHENIX U4+ on the Treatment of Urinary Incontinence

Phase: N/A Priority: Normal
NCT ID: NCT05202717 Org: User:
Start: 01/31/22 End: 12/31/22 Due: 12/31/23

A Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT06134063 Org: User:
Start: 11/30/23 End: 03/31/25 Due: 03/31/26

Apatinib for Inoperable Advanced Chondrosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04260113 Org: User:
Start: 10/01/19 End: 04/01/20 Due: 04/01/21

Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)

Phase: N/A Priority: Normal
NCT ID: NCT04516837 Org: User:
Start: 08/31/20 End: 08/31/22 Due: 08/31/23

Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy

Phase: N/A Priority: Normal
NCT ID: NCT02360761 Org: User:
Start: 01/31/16 End: 01/31/22 Due: 01/31/23

Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT06946654 Org: User:
Start: 05/20/25 End: 03/31/27 Due: 03/31/28

SJOV vs. HFNO for Hypoxia During Procedural Sedation at High Altitudes

Phase: N/A Priority: Normal
NCT ID: NCT05474287 Org: User:
Start: 10/14/22 End: 02/28/23 Due: 02/28/24

Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML

Phase: N/A Priority: Normal
NCT ID: NCT06452732 Org: User:
Start: 11/01/24 End: 06/30/26 Due: 06/30/27